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Measurement of Ploidy and Cell Proliferation
in the Rodent Liver
by Jerry A. Styles1 2
In most investigations of cell proliferation in vivo, the population under study consists of
mononuclear diploid cells that undergo replication via normal complete division cycles.
Because the phenomena associated with the cell cycle are sequential, only one is normally mea-
sured and it is usually adequate to quantify the proliferative activity in one of two ways. The
first involves labeling the cells undergoing semi-conservative DNA synthesis with a radioactive
DNA precursor, preparing autoradiographs of histological sections, and counting labeled
nuclei. The other commonly studied parameter of cell proliferation is mitotic activity. The liv-
ers ofrats and mice, unlike those ofother mammals, consist mainly ofhepatocytes that contain
two classes ofcell with respect to nuclei and several ploidy classes. These classes ofhepatocytes
arise as the result of modified cell division cycles. The peculiar cytological composition of the
rodent liver has, until recently, caused difficulties in the measurement and interpretation of
cell ploidy and cell proliferation by the above methods. Flow cytometry and fluorescence-acti-
vated cell sorting used in conjunction with quantitative fluorescent stains for DNA and fluores-
cently labeled antibodies to bromodeoxyuridine have permitted the rapid and precise quantifi-
cation of cell proliferative activity in the rodent liver. Studies using these techniques have
revealed that proliferative activity of hepatocytes may occur in different subpopulations of
cells depending on the kind oftoxicological injury inflicted on the animal.
Introduction
Cell division is a fundamental biological phenomenon
that has been studied in many organisms and tissues.
For most adult tissues in which cell renewal occurs,
the cell cycle is a predictable process and normally
involves complete cycles in a fraction of the cell popu-
lation. These cycles involve diploid cells, each ofwhich
replicates its genome and then segregates the result-
ing daughter chromosomes between diploid daughter
cells, replacing cells that have been lost due to death or
ablation. Cell loss and renewal in an adult organ or tis-
sue takes place in a controlled manner, with the rate of
cell renewal in an unperturbed organ having a charac-
teristic value. Thus, in adult tissues the size of a cell
population is maintained at a constant level by a cell
flux, and any change in the components of the flux
(rate of cell division, lifespan of cells, or rate of death)
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will alter the size of the population. Of these parame-
ters, the easiest to study and quantify is cell division,
although the process of cell death (including pro-
grammed cell death or apoptosis) has increasingly
occupied the attentions of investigators (1,2). In toxi-
cology, changes in cell division cycle kinetics elicited
by xenobiotics, resulting either in degeneration, regen-
eration, or hyperplasia, have long been considered to
be important events in the etiology ofpathological con-
ditions.
In eukaryotic organisms, cell division is under the
control of an array of genes that are collectively
referred as the cell division cycle (cdc) genes. These
have been most extensively studied in yeasts and
other lower eukaryotes, but mammalian homologues
have been described that, not surprisingly, exhibit a
considerable degree of conservation (3-6). Further-
more, evidence is emerging that some cdc genes in
mammals are homologous to proto-oncogenes (7-9).
Cell Division and the Development
of Polyploidy in the Rodent Liver
Afterbirth, the mammalian liverundergoes a consid-
erable increase in size by normal cell division ofall the
cell types present. In rodents, these normal division
cycles soon undergo a change in control in theJ. A. STYLES
parenchymal cells such that, after about 2 weeks of
age, binucleated hepatocytes arise (10,11). The forma-
tion of binucleated cells appears to be due to the sup-
pression of cytokinesis, the final phase of the division
cycle, rather than to cell fusion, because labeling
experiments have revealed the presence oflabel in bi-
nucleates (11-14). Shortly after the appearance of bi-
nucleated cells, polyploid (tetraploid) mononucleated
cells are formed. The mechanism for the genesis of
mononucleated tetraploid hepatocytes is not complete-
ly clear but appears to occur via binucleated cells:
some in vitro studies suggest that S phase occurs
simultaneously in both the nuclei, which then enter
mitosis when the two separate spindles fuse and a sin-
gle metaphase plate forms. Anaphase, telophase, and
cytokinesis follow, resulting in the formation of two
mononucleated tetraploid daughter cells (15).
Alternatively, it has been suggested from time-lapse
and electron microscopic studies that the two nuclei
undergo S phase simultaneously and then enter mito-
sis, in which a single spindle is formed, and the subse-
quent chromosomal segregation and cytokinesis are
normal, with the subsequent production of two
tetraploid cells (16).
In the guinea pig, the process of polyploidization is
limited to the production ofa small fraction ofbinucle-
ated hepatocytes (17), and in the hamster a small popu-
lation of tetraploid cells also appears (17), but in rats
and mice polyploidization affects the majority ofhepa-
tocytes and is a progressive phenomenon that contin-
ues throughout the life of the animal (11-14). In rats
the rate ofpolyploidization slows markedly by the age
of about 10 weeks and the liver consists mainly of
tetraploid cells (2 x 2n and 4n) and some octoploids (2 x
4n and 8n), but in the mouse the phenomenon pro-
gresses to a greater extent, and higher multiples ofthe
diploid DNA content may be observed as the animal
ages. The proportion of binucleated hepatocytes is
characteristic of a given rodent species and remains
fairly constant throughout life (11,12). This indicates
that some binucleated cells are intermediates between
ploidy states and may undergo a further modified divi-
sion cycle toproduce the succeedinghigherploidy level.
Although the mechanism by which binucleation and
polyploidization occur in rodent hepatocytes has been
partly elucidated, there is as yet no explanation as to
its significance. The behavior of the rodent liver in
response to various types of injury suggests that is
influenced by the ploidy conditions ofthe hepatocytes.
Cell Proliferation in Rodent Liver
In the adult mammalian liver, there is almost no cell
proliferative activity. In comparison with tissues such
as the bone marrow, intestinal epithelium, or the skin,
where mitotic activity may easily be observed in sec-
tioned material, the appearance ofa mitotic figure in a
liver section is extremely rare, even after administra-
tion of a mitotic blocking agent such as colchicine.
After mechanical or toxic injury, however, the liver
undergoes rapid and extensive proliferation until the
weight of the organ is restored to normal, at which
point the rate of cell division subsides to its normal,
near-quiescent levels.
DNA-reactive hepatocarcinogens induce changes in
the proportions of the different ploidy and nuclearity
classes in the livers of rats and mice (19-28). The car-
cinogens appear to provide cell division initially in rat
and mouse binucleated hepatocytes, which undergo
cytokinesis, thus completing the cell cycle and reduc-
ingthe proportion ofbinucleated cells (29). Subsequent
to this stage, some diploid cells acquire constitutive
cycling capacity and give rise to morphologically and
biochemically altered foci that consist mainly ofdiploid
cells (26). It is not known whether any of these foci
originate from the binucleated cells that divided, but
the change in control ofthe division cycle in these cells
probablyinvolves alterations in expression ofcdcgenes.
There are chemicals that stimulate cell division in
the hepatocyte population ofrodents at non-necrogenic
doses-a few, such as 4-acetylaminofluorene, appear to
be mitogenic but non-carcinogenic (30), while a large
and structurally diverse group of chemicals induces
liver growth and cancer (31). The compounds in the lat-
ter group are non-DNA reactive (32-40), and they elic-
it liver growth and cancer that is rodent specific (31).
The liver growth phenomena that are induced are
hepatocyte hypertrophy (smooth endoplasmic reticu-
lum proliferation and usually peroxisome proliferation)
and hyperplasia (41-46). Both these phenomena are
induced acutely by peroxisome proliferators, but with
continued administration of the chemicals only the
increased levels of peroxisomes are maintained (31).
The hyperplasia appears to occur principally in a frac-
tion of the binucleated hepatocyte population (47-51).
Unlike the response elicited by genotoxic hepatocar-
cinogens, where the cytokinesis is not preceded by S
phase and the cells simply complete their interrupted
cycle, the liver growth-inducing agents elicit S phase
in the binucleates, which then proceed via the normal
route for polyploidization, each producing two daugh-
termononucleated tetraploid cells.
Measurement of Cell Proliferation in
Rodent Liver
In most organs in which cell proliferation occurs, the
cell cycle proceeds through a series of predictable
stages, and each progenitor diploid cell gives rise to
two diploid daughter cells per cycle. The occurrence of
cell division is usually detected and quantified in one of
two ways: by detecting DNA replication during S
phase and by observing mitosis.
The occurrence of S phase has, until recently, been
studied through the use of radiolabeled precursors,
usually tritiated thymidine (for autoradiography of
sectioned material or cell cultures). The advent ofbro-
modeoxyuridine (BrdU) labeling and its detection by
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monoclonal antibodies has permitted the study of S
phase by nonradiolabeling techniques in tissue sec-
tions, cultured cells, and in cell suspensions by flow
cytometry.
The duration ofthe G1 and G2 phases ofthe cell cycle
varies within and between cell types (52,53); S phase
typically lasts 6-12 hr. and mitosis is usually complete
in less than 1 hr. In any method used to detect the
occurrence of S phase, the sensitivity of the assay is
increased directly in proportion to the persistence of
the label. Because all the DNA precursors have a short
biological half-life in vivo, maintenance ofadequate tis-
sue levels has commonly been achieved by repeated
injection or administration in drinking water. Owing to
the rate at which precursors are excreted, neither of
these methods is entirely satisfactory because the tis-
sue levels of labels fluctuate. Long periods of labeling
at constant tissue levels may be achieved through the
use of osmotic minipumps (43,54). Studies in rodent
liver in which radiolabeling and BrdU labeling by
minipump were compared showed quantitatively simi-
lar results (54). Methods to quantify the rate and dura-
tion ofS phase require pulse labeling methods to avoid
labeling S phase in daughter cells.
Mitosis (M phase), as an index of cell proliferative
activity, is intrinsically less sensitive than S phase
because it is of much shorter duration and hence the
fraction ofthe cycling population in M phase is smaller
than that in S phase. The detection of mitotic activity,
as distinct from observation of the stages of mitosis,
has been achieved by extending the period of
metaphase. This is most commonly done by arresting
cells in metaphase using the spindle poison colchicine.
The use ofcolchicine blockade is limited to a few hours
duration and is therefore less sensitive than S phase
labeling for cell proliferation. It has the advantage of
simplicity because it requires no additional preparative
stages to the usual histological procedures. Mitotic
cells may also be detected by flow cytometry in con-
junction with specific antibodies, providing the cell
type underinvestigation can withstand isolation (55).
Cell proliferative activity in the rodent liver my be
detected in the same way as in other organs and tis-
sues. The measurement ofproliferation is problematic
because the liver parenchymal cell population is not
homogeneous, consisting of mono- and binucleated
cells and multiples of the diploid component of DNA.
As described above, these subpopulations ofcells arise
as the result ofarrested or altered division cycles, and
the occurrence of S phase and mitosis cannot be quan-
tified and interpreted in conventional terms.
Studies on hepatocyte proliferation elicited in
response to various types of liver injury in rodents
have revealed that these involve different subpopula-
tions of hepatocytes. To elucidate which subpopula-
tions of hepatocytes are undergoing cell proliferation,
the most precise method requires the use of flow
cytometry, fluorescence-activated cell sorting, and con-
ventional microscopy (18,47). Hepatocytes in S phase
are labeled in vivo with BrdU, the livers perfused with
collagenase, and the resulting cell suspension separat-
ed by low-speed centrifugation (56-57). The hepato-
cyte fraction is fixed and the DNA stained with pro-
pidium iodide (PI). Cells in S phase, containing BrdU,
are reacted with BrdU antibody and stained with fluo-
rescein isothiocyanate (FITC). Both these fluo-
rochromes are excited by an argon-ion laser beam
tuned to emit at a wavelength of488 nm: the PI emits
red fluorescence and the FITC emits green. The cell
suspension is analyzed and sorted simultaneously
using two-fluorescence flow cytometry. This method
allows the ploidy of the cells and the incidence of cells
in S phase in different ploidy groups to be determined.
The cells are sorted onto slides and examined micro-
scopically using fluorescence optics to determine the
proportion ofmono- and binucleated cells in S phase in
comparison to the total fraction ofbinucleated cells.
The chief deficiency in the use of flow cytometry is
due to the obligatory use of cell suspensions and the
resulting loss ofall information relating to the anatom-
ical location ofS phase activity. This deficiency may, at
least in part, be remedied by combining the use offlow
cytometry on hepatocyte suspensions with light micro-
scopic examination ofliver sections in which the BrdU
in S phase cells is visualized by immunohistochemical
stains.
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